What is Dr. Zubair Khalid's research focus?

Dr. Zubair Khalid specializes in molecular virology, mRNA vaccine development, and computational biology, with a focus on avian pathogens like IBDV and Avian Reovirus.

Where is Dr. Zubair Khalid currently working?

Dr. Zubair Khalid is a Postdoctoral Research Associate at the University of Maryland (UMD), specifically within the Department of Animal and Avian Sciences.

Single Strand Break Repair: Mechanisms and Significance

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Introduction to Single Strand Break Repair

What is a Single Strand Break?

A single strand break (SSB) is a discontinuity in the phosphodiester backbone of one of the two DNA strands. Unlike a double strand break (DSB), which severs both strands, an SSB leaves the complementary strand intact, preserving the overall double-helical structure. The break typically involves a missing nucleotide, a damaged sugar moiety, or a nick where the 3'-hydroxyl and 5'-phosphate termini are no longer adjacent or are chemically modified. SSBs are the most common type of DNA lesion, with estimates suggesting that a single human cell experiences tens of thousands of these events per day under normal physiological conditions.

Single strand break repair (SSBR) is the dedicated pathway that detects these lesions, processes the damaged termini, fills the resulting gap, and restores the phosphodiester backbone. SSBR is a branch of the broader DNA Repair network and shares several enzymatic components with Base Excision Repair. However, SSBR is mechanistically distinct because it does not require the removal of a damaged base—the lesion is already a break in the sugar-phosphate backbone.

Why SSBR Matters

The consequences of unrepaired SSBs are severe. A persistent SSB can stall DNA replication forks, leading to replication collapse and the formation of toxic Double Strand Breaks in DNA. During transcription, SSBs can block RNA polymerase progression, triggering transcriptional arrest and potentially activating degradation pathways. Additionally, SSBs in the genome can serve as substrates for PARP1 hyperactivation, which depletes cellular NAD⁺ and ATP pools, ultimately leading to energy crisis and cell death.

The clinical importance of SSBR is underscored by the fact that inherited defects in SSBR proteins cause severe neurodegenerative diseases, including ataxia-oculomotor apraxia and spinocerebellar ataxia with axonal neuropathy. These disorders highlight the particular vulnerability of post-mitotic neurons to SSB accumulation, as these cells cannot dilute damage through replication and rely heavily on efficient repair.

Sources of Single Strand Breaks

Endogenous Sources

Reactive oxygen species (ROS) are the primary endogenous source of SSBs. Superoxide, hydrogen peroxide, and hydroxyl radicals are generated as byproducts of mitochondrial oxidative phosphorylation, peroxisomal fatty acid oxidation, and various enzymatic reactions. The hydroxyl radical (•OH) is particularly damaging, as it can abstract hydrogen atoms from the deoxyribose sugar, leading to sugar fragmentation and direct strand scission. This process produces SSBs with damaged termini—typically 3'-phosphate or 3'-phosphoglycolate groups instead of the normal 3'-hydroxyl, and 5'-hydroxyl instead of 5'-phosphate.

Abasic (AP) sites are another major endogenous source. Spontaneous depurination occurs at a rate of approximately 10,000 events per cell per day. When an AP site is cleaved by AP endonuclease 1 (APE1) during Base Excision Repair, an SSB intermediate is generated. If this intermediate is not promptly ligated, it becomes a persistent SSB requiring SSBR.

Topoisomerase failures represent a third endogenous source. Topoisomerase I (TOP1) forms a covalent intermediate with DNA, the cleavage complex, to relieve torsional stress during transcription and replication. Normally, TOP1 religates the DNA after strand rotation. However, abortive catalysis can leave TOP1 covalently trapped on the 3'-phosphate terminus of a nick, creating a topoisomerase-DNA covalent complex that must be resolved by tyrosyl-DNA phosphodiesterase 1 (TDP1). Similarly, topoisomerase II failures can generate protein-linked DSBs, but the SSB-associated lesions are more common.

Exogenous Sources

Ionizing radiation (IR) is a well-characterized exogenous source of SSBs. X-rays and gamma rays deposit energy in biological tissue, generating ROS through water radiolysis and causing direct ionization of DNA. Low-LET radiation (such as X-rays) produces approximately 1000 SSBs per Gy per cell, compared to roughly 40 DSBs per Gy. The SSBs induced by IR frequently have clustered damage—multiple lesions within one or two helical turns—which complicates repair.

Ultraviolet (UV) radiation primarily causes photoproducts (cyclobutane pyrimidine dimers and 6-4 photoproducts), but these are repaired by nucleotide excision repair, which generates SSB intermediates. Thus, UV indirectly creates SSBs during the repair process itself.

Chemotherapeutic agents also induce SSBs. Camptothecin and its derivatives (topotecan, irinotecan) stabilize the TOP1 cleavage complex, converting transient nicks into persistent protein-linked SSBs. Alkylating agents such as methyl methanesulfonate (MMS) generate damaged bases that are processed by BER, again producing SSB intermediates. Bleomycin, a glycopeptide antibiotic used in cancer therapy, directly fragments DNA and produces SSBs with 3'-phosphoglycolate termini.

Detection of Single Strand Breaks

PARP1 and PARylation

The primary sensor of SSBs is poly(ADP-ribose) polymerase 1 (PARP1). PARP1 is an abundant nuclear protein, present at approximately 1–2 million copies per cell, and it binds with high affinity to DNA breaks. PARP1 contains three zinc finger domains that recognize structural distortions at SSBs, particularly the exposed sugar-phosphate backbone and the loss of base stacking. Upon binding, PARP1 undergoes a conformational change that activates its catalytic domain.

Activated PARP1 cleaves NAD⁺ into nicotinamide and ADP-ribose, then polymerizes ADP-ribose units onto itself and other acceptor proteins. This process, called poly(ADP-ribose)ylation or PARylation, creates long, branched chains of poly(ADP-ribose) (PAR) that can exceed 200 units in length. The PAR chains serve as a recruitment signal, docking repair factors to the damage site. PARP1 automodification also causes electrostatic repulsion between the negatively charged PAR chains and DNA, promoting PARP1 dissociation from the break after repair is initiated.

The kinetics of PARP1 activation are rapid: PAR synthesis peaks within seconds of damage induction and declines within minutes as the break is repaired. This transient PARylation is critical for the ordered assembly and disassembly of the repair complex. PARP2, a related enzyme, also contributes to SSB detection but plays a minor role compared to PARP1.

Other Sensors

While PARP1 is the dominant SSB sensor, other proteins can detect breaks in specific contexts. Poly(ADP-ribose) glycohydrolase (PARG) degrades PAR chains and is essential for turning off the PARP1 signal. The DNA damage checkpoint kinase ATM is primarily activated by DSBs, but it also responds to SSBs in certain contexts, particularly when replication forks encounter unrepaired nicks.

The MRE11-RAD50-NBS1 (MRN) complex, which is central to Double Strand Break Repair, can also recognize SSBs that arise as intermediates during replication. However, for canonical SSBR in G1 phase, PARP1 is the principal sensor, and its inhibition is sufficient to abrogate SSB detection and repair.

The Core Steps of Single Strand Break Repair

SSBR proceeds through four sequential steps: detection, end processing, gap filling, and ligation. The entire process typically completes within minutes in cultured cells, with the rate-limiting step being end processing when the termini are damaged.

Detection: PARP1 binds to the SSB and synthesizes PAR chains, recruiting downstream repair factors. PARP1 then dissociates, allowing access to the break site.

End processing: The damaged termini are converted to the canonical 3'-hydroxyl and 5'-phosphate ends required for gap filling and ligation. This step is catalyzed by a variety of enzymes depending on the nature of the damage.

Gap filling: DNA polymerase β (Polβ) inserts one or a few nucleotides to fill the gap, using the intact complementary strand as a template.

Ligation: DNA ligase IIIα (LigIIIα) seals the nick, restoring the intact phosphodiester backbone.

End Processing

The chemical nature of the SSB termini determines which end-processing enzymes are required. Normal SSBs produced by nucleases have 3'-hydroxyl and 5'-phosphate termini and can proceed directly to gap filling. However, most SSBs have damaged termini that must be converted.

3'-phosphate termini: Produced by ROS-mediated sugar fragmentation and by APE1 cleavage of AP sites. Polynucleotide kinase 3'-phosphatase (PNKP) removes the 3'-phosphate, generating a 3'-hydroxyl.
3'-phosphoglycolate termini: Produced by ionizing radiation and bleomycin. These are removed by APE1, which has 3'-phosphodiesterase activity, or by TDP1.
5'-hydroxyl termini: Produced by ROS. PNKP phosphorylates the 5'-hydroxyl to generate 5'-phosphate.
5'-AMP termini: Produced by abortive ligation reactions. Aprataxin (APTX) removes the adenylate moiety.
Protein-linked termini: Trapped TOP1 cleavage complexes are resolved by TDP1, which hydrolyzes the phosphodiester bond between the TOP1 tyrosine and the 3'-phosphate of DNA.

Gap Filling by DNA Polymerase

After end processing, DNA polymerase β (Polβ) fills the gap. Polβ is a small (39 kDa) polymerase with two enzymatic activities: an N-terminal lyase domain that removes 5'-deoxyribose phosphate (dRP) residues and a C-terminal polymerase domain that adds nucleotides. Polβ is well-suited for SSBR because it can fill gaps of one to six nucleotides with high fidelity, and its dRP lyase activity is essential for Base Excision Repair as well.

Polβ is recruited to the break site through its interaction with XRCC1, which serves as a scaffold protein. The polymerase activity of Polβ is distributive—it adds one nucleotide at a time and dissociates after each incorporation. For gaps longer than one nucleotide, Polβ can remain processive for short stretches, but its primary role is in short-patch repair.

Ligation by DNA Ligase

The final step is catalyzed by DNA ligase IIIα (LigIIIα), which seals the nick between the 3'-hydroxyl and 5'-phosphate. LigIIIα is a 103 kDa protein that forms a stable complex with XRCC1. The ligation reaction proceeds through three steps:

Adenylation: LigIIIα reacts with ATP, forming a covalent ligase-adenylate intermediate and releasing pyrophosphate.
AMP transfer: The AMP moiety is transferred to the 5'-phosphate at the nick, activating it.
Phosphodiester bond formation: The 3'-hydroxyl attacks the activated 5'-phosphate, forming the phosphodiester bond and releasing AMP.

LigIIIα is unique among human DNA ligases in that it contains a zinc finger domain that enhances its affinity for nicked DNA. The enzyme is essential for SSBR; its loss is embryonic lethal in mice, and its depletion in cells leads to accumulation of unrepaired SSBs.

Key Proteins in Single Strand Break Repair

Scaffold Proteins

XRCC1 (X-ray repair cross-complementing protein 1) is the central scaffold of SSBR. This 70 kDa protein has no enzymatic activity but contains multiple protein interaction domains that organize the repair complex. XRCC1 interacts with PARP1, PNKP, APTX, TDP1, Polβ, and LigIIIα, bringing these enzymes into proximity at the break site. XRCC1 also contains a BRCA1 C-terminal (BRCT) domain that binds to PAR chains, providing an additional mechanism for recruitment to damage sites.

XRCC1 is constitutively associated with LigIIIα, and this complex is stable even in the absence of DNA damage. Upon PARP1 activation, XRCC1-LigIIIα is recruited to the break, where it displaces PARP1 and coordinates the downstream repair steps. XRCC1-deficient cells are hypersensitive to ionizing radiation and alkylating agents, and XRCC1 mutations in humans cause a severe neurodegenerative phenotype.

End Processing Enzymes

PNKP (Polynucleotide kinase 3'-phosphatase) is a bifunctional enzyme with both 3'-phosphatase and 5'-kinase activities. It converts 3'-phosphate to 3'-hydroxyl and 5'-hydroxyl to 5'-phosphate, generating the canonical termini required for gap filling and ligation. PNKP is recruited to SSBs through its interaction with XRCC1, and its activity is stimulated by PAR binding. Mutations in PNKP cause a severe neurodevelopmental disorder with microcephaly and seizures.

APTX (Aprataxin) removes adenylate groups from 5'-phosphate termini. These 5'-AMP adducts arise when DNA ligases abortively adenylate the 5'-phosphate and then fail to complete the ligation reaction. APTX hydrolyzes the AMP-DNA phosphodiester bond, generating a clean 5'-phosphate. APTX mutations cause ataxia-oculomotor apraxia type 1 (AOA1), a neurodegenerative disorder.

TDP1 (Tyrosyl-DNA phosphodiesterase 1) hydrolyzes the covalent bond between TOP1 and the 3'-phosphate of DNA, releasing the trapped topoisomerase. TDP1 also processes 3'-phosphoglycolate termini generated by ionizing radiation. TDP1 mutations cause spinocerebellar ataxia with axonal neuropathy (SCAN1).

APE1 (AP endonuclease 1), in addition to its role in BER, has 3'-phosphodiesterase activity that removes 3'-phosphoglycolate and other 3'-blocking groups. APE1 is the major abasic endonuclease in human cells and contributes to SSBR when the break is adjacent to an AP site.

Protein	Function in SSBR	Associated Disease
PARP1	SSB sensor, PAR synthesis	Not directly linked to inherited disease
XRCC1	Scaffold, coordinates repair	Severe neurodegeneration (mouse models)
PNKP	3'-phosphatase, 5'-kinase	Microcephaly, seizures, neurodegeneration
APTX	Removes 5'-AMP adducts	Ataxia-oculomotor apraxia type 1
TDP1	Resolves TOP1-DNA adducts	Spinocerebellar ataxia with axonal neuropathy
Polβ	Gap filling	Not directly linked to inherited disease
LigIIIα	Nick sealing	Embryonic lethal (mouse)
APE1	3'-phosphodiesterase	Not directly linked to inherited disease

Methods to Study Single Strand Break Repair

Comet Assay

The alkaline comet assay (single-cell gel electrophoresis) is the most widely used method to measure SSBs. Cells are embedded in agarose on a microscope slide, lysed to remove membranes and proteins, and subjected to electrophoresis under alkaline conditions (pH > 13). The alkaline conditions denature DNA and cause SSBs to become DSBs, allowing broken DNA fragments to migrate toward the anode. The resulting "comet" tail is visualized by fluorescence microscopy, and the tail moment (the product of tail length and fraction of DNA in the tail) is proportional to the number of breaks.

The comet assay can be modified to detect specific types of lesions. For example, including a digestion step with endonuclease III (which cleaves oxidized pyrimidines) or formamidopyrimidine DNA glycosylase (which cleaves oxidized purines) converts oxidized bases into SSBs, allowing their detection. The neutral comet assay (pH 8) detects only DSBs and can be used to distinguish SSB from DSB formation.

In Vitro Repair Assays

Biochemical reconstitution of SSBR allows detailed mechanistic studies. A typical in vitro assay uses a plasmid or oligonucleotide substrate containing a defined SSB, purified repair proteins, and reaction buffer containing 50 mM Tris-HCl (pH 7.5), 50 mM KCl, 5 mM MgCl₂, 1 mM DTT, and 100 μM ATP. The reaction is incubated at 37°C for 30 minutes, and repair is monitored by the conversion of the nicked substrate to the closed circular form, which can be separated by agarose gel electrophoresis.

For quantitative analysis, radiolabeled substrates are used. A 5'-³²P-labeled oligonucleotide containing a nick is incubated with repair proteins, and the products are analyzed by denaturing polyacrylamide gel electrophoresis. Successful ligation is detected by the appearance of a full-length product. This approach allows measurement of repair efficiency and identification of the specific end-processing requirements for different types of SSBs.

PARP Inhibition Assays

Because PARP1 activation is the first step in SSBR, measuring PAR synthesis provides a readout of SSB detection. Cells are treated with a DNA-damaging agent, and PAR levels are quantified by immunoblotting with anti-PAR antibodies or by ELISA. Alternatively, a radioactive assay can be used: permeabilized cells are incubated with ³H-NAD⁺, and the incorporation of radioactivity into acid-precipitable material (PAR chains) is measured.

The PARP inhibitor sensitivity assay is a functional test of SSBR capacity. Cells are treated with increasing concentrations of a PARP inhibitor such as olaparib, and cell survival is measured by colony formation or viability assays. Cells with defects in SSBR (e.g., XRCC1-deficient or PNKP-mutant cells) are hypersensitive to PARP inhibition because they cannot repair the SSBs that accumulate when PARP1 is inhibited.

Fluorescence-Based Repair Assays

Live-cell imaging of SSBR uses fluorescently tagged repair proteins. PARP1-GFP or XRCC1-GFP fusion proteins are expressed in cells, and laser microirradiation is used to induce localized DNA damage in a defined nuclear region. The recruitment of the fluorescent protein to the damage site is monitored by time-lapse microscopy, and the kinetics of recruitment and dissociation provide information about the repair process.

A more quantitative approach uses a fluorescent SSB reporter. A plasmid containing a defined SSB in the coding sequence of a fluorescent protein (e.g., GFP) is transfected into cells. If the SSB is repaired, the GFP gene is restored and fluorescence is observed. This assay allows measurement of repair efficiency in living cells and can be adapted to study specific types of SSBs by introducing defined chemical modifications at the break site.

Single Strand Break Repair and Human Disease

Neurodegenerative Diseases

The strongest link between SSBR defects and human disease is in the nervous system. Post-mitotic neurons are particularly vulnerable to SSB accumulation because they cannot dilute damage through cell division, and they have high metabolic rates that generate substantial ROS. Furthermore, neurons rely heavily on transcription for their function, and SSBs that block RNA polymerase can trigger neurodegeneration.

Ataxia-oculomotor apraxia type 1 (AOA1) is caused by mutations in APTX. Patients present with progressive cerebellar ataxia, oculomotor apraxia (difficulty initiating voluntary eye movements), and peripheral neuropathy. The disease typically begins in childhood or adolescence and progresses over decades. APTX deficiency leads to accumulation of 5'-adenylated DNA intermediates, which are toxic to neurons.

Spinocerebellar ataxia with axonal neuropathy (SCAN1) is caused by mutations in TDP1. Patients develop cerebellar ataxia and peripheral neuropathy in adolescence. TDP1 deficiency results in persistent TOP1-DNA covalent complexes, particularly in neurons with high transcriptional activity.

PNKP mutations cause a spectrum of disorders including microcephaly with seizures and ataxia-oculomotor apraxia type 4. The severity of the phenotype correlates with the residual enzymatic activity of the mutant PNKP protein.

Cancer and SSBR

While inherited SSBR defects primarily cause neurodegeneration, somatic alterations in SSBR genes contribute to cancer. PARP1 is overexpressed in many tumor types, and PARP inhibitors have become important therapeutic agents. The mechanism of PARP inhibitor cytotoxicity is based on synthetic lethality: tumors with defects in homologous recombination (particularly BRCA1 or BRCA2 mutations) are exquisitely sensitive to PARP inhibition because they cannot repair the replication-associated DSBs that arise from unrepaired SSBs.

PARP inhibitors trap PARP1 on DNA, creating a more toxic lesion than the original SSB. This trapped PARP1-DNA complex blocks replication forks and requires homologous recombination for resolution. In BRCA-deficient cells, this repair pathway is unavailable, leading to cell death. This therapeutic strategy highlights the intimate connection between SSBR and Double Strand Break Repair: SSBs that are not repaired become DSBs during replication, and the cell's ability to handle these DSBs determines its sensitivity to PARP inhibition.

Polymorphisms in XRCC1 have been associated with altered cancer risk in some epidemiological studies, although the effects are modest and inconsistent across populations. The arginine-to-glutamine polymorphism at codon 399 (XRCC1 Arg399Gln) is the most studied variant and may affect DNA repair capacity, but functional consequences remain debated.

Common Pitfalls and Misconceptions in SSBR

SSBR vs. BER

Students frequently confuse SSBR with Base Excision Repair, and this confusion is understandable—the two pathways share many components and are intimately linked. The key distinction is the initiating lesion:

BER repairs damaged or inappropriate bases (e.g., oxidized bases, uracil, alkylated bases). The pathway begins with a DNA glycosylase that removes the damaged base, creating an AP site. APE1 then cleaves the AP site, generating an SSB intermediate that is processed by the same downstream enzymes used in SSBR.
SSBR repairs pre-existing breaks in the phosphodiester backbone. There is no base damage to remove; the lesion is already a nick or gap.

The distinction becomes blurred when BER is described as having "short-patch" and "long-patch" subpathways. Short-patch BER (which handles the majority of lesions) uses Polβ and LigIIIα, exactly the same enzymes as SSBR. The difference is that BER requires the initial steps of base removal and AP site cleavage, while SSBR begins directly at the break.

A useful way to think about this: BER generates SSBs as intermediates, and the completion of BER from the SSB intermediate onward is essentially SSBR. However, SSBR can also repair SSBs that arise independently of base damage, such as those caused by ionizing radiation or topoisomerase failure.

SSBR vs. DSBR

Another common error is confusing SSBR with Double Strand Break Repair or Double Stranded Break Repair. The fundamental difference is the number of broken strands:

SSBR repairs a break in one strand, using the intact complementary strand as a template. The process is relatively simple and error-free, involving end processing, gap filling, and ligation.
DSBR repairs breaks in both strands and is more complex. The two major pathways are Non Homologous End Joining Repair (NHEJ), which directly ligates the broken ends, and homologous recombination, which uses a sister chromatid as a template. DSBR is more error-prone than SSBR, particularly NHEJ, which can introduce small insertions or deletions.

The repair proteins are also distinct. SSBR uses PARP1, XRCC1, Polβ, and LigIIIα. DSBR uses the MRN complex, ATM, Ku70/Ku80, DNA-PKcs, and LigIV. PARP1 does play a role in DSBR, particularly in alternative NHEJ pathways, but its primary function is in SSBR.

A critical point for exams: SSBs that are not repaired can become DSBs during replication. When a replication fork encounters an SSB, the fork can collapse, converting the SSB into a one-ended DSB. This is why PARP inhibitors are toxic to cells with homologous recombination defects—the unrepaired SSBs become DSBs that cannot be repaired.

Other Misconceptions

"PARP1 repairs the break": PARP1 detects the break and signals for repair, but it does not directly participate in end processing, gap filling, or ligation. PARP1 is a sensor and signal transducer, not a repair enzyme.

"All SSBs are the same": The chemical nature of the termini varies widely. A clean nick with 3'-hydroxyl and 5'-phosphate is easy to repair, while a break with 3'-phosphoglycolate and 5'-hydroxyl requires multiple processing steps. The complexity of the termini determines the repair kinetics and the specific enzymes required.

"SSBR is error-free": While SSBR is generally accurate because it uses the complementary strand as a template, errors can occur. Polβ has a low but measurable error rate, and if gap filling is inaccurate, a mutation can be introduced. However, the error rate of SSBR is much lower than that of DSBR via NHEJ.

"PARP inhibitors block SSBR completely": PARP inhibitors prevent PAR synthesis, but they do not simply block SSBR. The inhibitors trap PARP1 on DNA, creating a protein-DNA crosslink that is more toxic than the original SSB. This trapping effect is the basis for the therapeutic efficacy of PARP inhibitors in cancer.

Summary and Practical Takeaways

Key Points to Remember

SSBs are the most common DNA lesion, arising from ROS, topoisomerase failures, ionizing radiation, and as intermediates in BER.
PARP1 is the primary SSB sensor, detecting breaks and synthesizing PAR chains that recruit repair proteins.
SSBR has four steps: detection (PARP1), end processing (PNKP, APTX, TDP1, APE1), gap filling (Polβ), and ligation (LigIIIα).
XRCC1 is the central scaffold, organizing the repair complex and linking detection to repair.
Defects in SSBR cause neurodegeneration, including AOA1 (APTX), SCAN1 (TDP1), and PNKP-associated disorders.
PARP inhibitors exploit SSBR defects in cancer therapy through synthetic lethality with homologous recombination deficiency.
SSBR is distinct from BER and DSBR, although it shares components with BER and is linked to DSBR through replication fork collapse.

Exam Tips

When asked to describe SSBR, always mention the four steps in order: detection, end processing, gap filling, ligation.
Know which enzyme handles which type of damaged terminus: PNKP for 3'-phosphate and 5'-hydroxyl, APTX for 5'-AMP, TDP1 for TOP1 adducts, APE1 for 3'-phosphoglycolate.
Understand the relationship between SSBR and BER: BER generates SSB intermediates that are repaired by SSBR enzymes.
Be able to explain why neurons are particularly vulnerable to SSBR defects: they are post-mitotic, have high metabolic rates, and depend on transcription.
Know the clinical significance of PARP inhibitors: they are used to treat BRCA-mutant cancers through synthetic lethality.

Frequently Asked Questions

What is single strand break repair?

Single strand break repair (SSBR) is the cellular pathway that repairs discontinuities in one strand of the DNA double helix. The pathway detects the break, processes damaged termini to generate canonical 3'-hydroxyl and 5'-phosphate ends, fills the gap using the intact complementary strand as a template, and seals the nick. SSBR is essential for maintaining genome integrity and preventing the conversion of SSBs into more toxic double strand breaks during replication.

How does single strand break repair differ from base excision repair?

Base excision repair (BER) repairs damaged or inappropriate bases, such as oxidized bases, uracil, or alkylated bases. BER begins with a DNA glycosylase that removes the damaged base, creating an abasic (AP) site. AP endonuclease then cleaves the AP site, generating an SSB intermediate. From this point, BER and SSBR converge, using the same downstream enzymes (Polβ, LigIIIα, XRCC1). SSBR, however, repairs pre-existing breaks that do not require base removal. The key distinction is the initiating lesion: a damaged base for BER versus a broken phosphodiester backbone for SSBR.

What is the role of PARP1 in single strand break repair?

PARP1 is the primary sensor of single strand breaks. It binds to the break site and synthesizes poly(ADP-ribose) (PAR) chains on itself and other proteins. This PARylation serves as a recruitment signal, bringing downstream repair factors such as XRCC1, PNKP, Polβ, and LigIIIα to the break. PARP1 then dissociates from the DNA, allowing the repair enzymes access to the lesion. PARP1 does not directly participate in end processing, gap filling, or ligation—it is a sensor and signal transducer.

What happens if single strand breaks are not repaired?

Unrepaired single strand breaks have several consequences. During DNA replication, an SSB can stall or collapse a replication fork, converting the SSB into a one-ended double strand break. This is highly toxic and can lead to chromosomal rearrangements or cell death. SSBs can also block transcription, preventing gene expression and potentially triggering degradation of the stalled RNA polymerase. Additionally, persistent SSBs cause sustained PARP1 activation, which depletes cellular NAD⁺ and ATP, leading to energy failure and necrosis.

Which diseases are associated with defects in single strand break repair?

Defects in SSBR primarily cause neurodegenerative disorders. Mutations in APTX cause ataxia-oculomotor apraxia type 1 (AOA1), characterized by progressive cerebellar ataxia and oculomotor apraxia. Mutations in TDP1 cause spinocerebellar ataxia with axonal neuropathy (SCAN1). Mutations in PNKP cause microcephaly with seizures and ataxia-oculomotor apraxia type 4. These disorders highlight the particular vulnerability of neurons to SSB accumulation. In cancer, somatic alterations in SSBR genes contribute to tumor development, and PARP inhibitors are used therapeutically to exploit SSBR defects in BRCA-mutant tumors.

How is single strand break repair studied experimentally?

SSBR is studied using several approaches. The alkaline comet assay measures SSB levels in individual cells by detecting DNA migration under electrophoresis. In vitro repair assays use defined DNA substrates with specific SSB lesions and purified repair proteins to reconstitute the pathway. PARP inhibition assays measure the cellular response to PARP inhibitors, which is a functional readout of SSBR capacity. Fluorescence-based assays using GFP-tagged repair proteins allow live-cell imaging of repair protein recruitment to laser-induced damage sites.

What is the difference between single strand break repair and double strand break repair?

Single strand break repair repairs a break in one DNA strand, using the intact complementary strand as a template. The process is relatively simple, involving end processing, gap filling by Polβ, and ligation by LigIIIα. Double strand break repair repairs breaks in both strands and is more complex. The two major pathways are non-homologous end joining (NHEJ), which directly ligates the broken ends, and homologous recombination, which uses a sister chromatid as a template. DSBR involves different proteins (Ku70/Ku80, DNA-PKcs, MRN complex, ATM, LigIV) and is more error-prone than SSBR, particularly NHEJ. Unrepaired SSBs can become DSBs during replication, linking the two pathways.

Key Takeaways

Single strand breaks are the most frequent DNA lesion, arising from reactive oxygen species, topoisomerase failures, ionizing radiation, and as intermediates in base excision repair.
SSBR proceeds through four ordered steps: PARP1-mediated detection, end processing to generate canonical termini, gap filling by DNA polymerase β, and ligation by DNA ligase IIIα.
XRCC1 serves as the central scaffold protein, coordinating the assembly of repair enzymes at the break site.
End processing enzymes are lesion-specific: PNKP handles 3'-phosphate and 5'-hydroxyl, APTX removes 5'-AMP adducts, TDP1 resolves topoisomerase-DNA covalent complexes, and APE1 removes 3'-phosphoglycolate.
Defects in SSBR cause severe neurodegenerative diseases, including ataxia-oculomotor apraxia type 1 (APTX mutations) and spinocerebellar ataxia with axonal neuropathy (TDP1 mutations).
PARP inhibitors are clinically used to treat BRCA-mutant cancers through synthetic lethality, exploiting the conversion of unrepaired SSBs into toxic DSBs during replication.
SSBR is mechanistically distinct from BER (which repairs damaged bases) and DSBR (which repairs breaks in both strands), although all three pathways are interconnected in the cellular DNA damage response.